Molecular Pathology Laboratory Network

Epstein Barr Virus by In-Situ Hybridization

Test Code
I EBER ISH
Associations
Infectious mononucleosis, Burkitt's lymphoma,Reed Sternberg cells Hodgkin's lymphoma, nasopharyngeal carcinoma, HIV infection
Methodology
Chromogenic in-situ Hybridization (CISH)
CPT Codes
88368 - Morphometric analysis, in situ hybridization
Turnaround Time
Less than 2 days
Specimen Requirements
  • Surgical samples received in 10% neutral buffered formalin or B Plus fixative
  • Formalin fixed paraffin embedded tissue
  • Previously prepared pathology materials (slides, smears, or other samples)
Send reports, history and differential diagnosis.
Specimen Stability
Prepared pathology materials, stable indefinitely at 18-25°C
Storage & Handling
Ship samples at ambient temperature.
Causes for Rejection
Improper specimen labeling; Inadequate tissue evaluation; Improper sample submission
Reference Range
EBER by ISH is performed on formalin-fixed paraffin-embedded tissues and the result is very similar to the traditional IHC slide - a brown (DAB) chromogen target location on a Hematoxylin counter-stained slide.
Description
EBV infection is associated with a variety of pathological conditions. The virus has been reported to be demonstrated in infectious mononucleosis, Burkitt's lymphoma, the Reed Sternberg cells of Hodgkin's disease and in nasopharyngeal carcinoma. In HIV infection, EBV has also been reported to be demonstrated in primary CNS lymphomas and oral hairy leukoplakia lesions.
The technique demonstrates cells latently-infected with EBV as it hybridizes to abundantly expressed Epstein-Barr virus-encoded RNA (EBER) transcripts which are concentrated in the nuclei of latently-infected cells.

Search Directory

A-Z Test Listing

A B C D E F H I J K L M N O P S T U W X Z

Directory